EFLM bursary recipients to attend the 3rd EFLM-EUMS Congress “Laboratory Medicine at the Clinical Interface” - EuroLabFocus 2014
July 23, 2014 - 18 bursary applications from 9 countries were received to attend the congress in Liverpool. The panel in charge of the selection had a hard task selecting the 5 recipients according to the following criteria:
1) Young participants (those in training or up to 5 years after completing training);
2) Having a poster abstract accepted;
3) Completeness of the required documentation;
4) List of publication with a high impact factor.
After a careful evaluation of the requests, the following 5 applicants were selected to receive the 5 EFLM bursaries to attend the congress in Liverpool:
- Katarzyna BERGMANN (Poland)
- Federica BRAGA (Italy)
- Judith GILLIS (The Netherlands)
- Eloide HANON (UK)
- Snežana JOVICIC (Serbia)
The bursary will cover the cost of the registration, travel and 3-night accommodation for a maximum of EUR 1200. The next EFLM bursary programme for Young Scientists is for the participation at the EFLM Postgraduate Course in Dubrovnik. We invite eligible people not to miss this oppurtunity! Further information at: http://www.dubrovnik-course.org/bursary
Key dates: new deadlines - 14th EFLM Postgraduate Continuous Course - Dubrovnik, October 25-26, 2014
July 22, 2014 - The local organizers of the 14th EFLM Postgraduate Continuous Course to be held in Dubrovnik, in order to meet the many requests received by the different National Society, have decided to definitively postpone key dates as follows:
- Deadline for ABSTRACT submission: August 22 http://www.dubrovnik-course.org/abstract
- Deadline for BURSARY applications: September 4 http://www.dubrovnik-course.org/bursary
- Deadline for early REGISTRATION FEE: September 15 http://www.dubrovnik-course.org/registration
We look forward to seeing you in Dubrovnik!
The EFLM publications' list is now available on the website
July 22, 2104 - The EFLM Communication Committee is proud to announce that the list of the EFLM Publications has been recently updated. In the EFLM web site section http://www.efcclm.eu/index.php/eflm-publications.html, the most relevant publications prepared by EFLM Committees or Working Groups or where EFLM played an important scientific role are listed in chronological order. Each paper is linked to the relative PDF downloadable by the website visitors.
We hope that this initiative can help our professional community to be updated with the most recent scientific and professional advances and to appreciate the role EFLM plays in the field of Laboratory Medicine.
14th EFLM Continuing Postgraduate Course in Clinical Chemistry and Laboratory Medicine - Dubrovnik, October 25-26, 2014
July 16, 2014 - We are very pleased that EFLM supports Continuing Professional Development by organising this traditional Course in Dubrovnik. The Scientific and Organising Committee has done a great job in gathering the recognized international experts, who will be presenting the latest news and findings in the field. The Scientific Program will discuss many new aspects in diagnosis type I and type II diabetes and early markers of pre-diabetes as well as diabetic complications.
We would like to draw your particular attention to the session dealing with new guidelines and recommendations for HbA1c testing in diagnosis and control of diabetes as well as how should HbA1c results be communicated to clinicians and how should EQAS results be communicated to laboratories.
The Course will be granted credits for Continuing Professional Education according to the National rule and Certified with lecture hours by Inter University Centre. Best poster will be awarded.
We proudly announce that bursaries from several resources are available for Young Congress participants. For more details, please visit: www.dubrovnik-course.org/bursary.
We look forward to welcoming you in Dubrovnik!
EFLM-UEMS EuroLabFocus Congress - Presidents invitation and postponement of the ‘early bird’ registration date
July 15, 2014 - We are delighted that Liverpool is hosting the most important clinical laboratory meeting in the UK
for nearly a decade. The 3rd EFLM-EUMS Congress “Laboratory Medicine at the Clinical Interface” – EuroLabFocus 2014 promises to be a key event in the calendar of all our organisations as we welcome our colleagues from across Europe in a conference that cuts across the traditional boundaries of laboratory medicine. The EFLM/UEMS/ACB scientific committee, led by Ian Watson, has designed a world class programme catering for individual specialties and in mind as well as current topics of relevance to specialists in laboratory medicine across Europe. With nearly 400 abstracts submitted from 25 countries we look forward to learning from each other’s practice and forging new links and friendships. Such links become increasingly important in our efforts to influence the delivery of high quality clinical practice across Europe. Read more
Report on the "V International Clinical Laboratory and Quality Symposium" organized by SEQC in Barcelona
July 8, 2014 - The "V International Clinical Laboratory and Quality Symposium" organised by the Spanish Society of Clinical Biochemistry and Molecular Pathology, under the auspices of EFLM, was successfully held in Barcelona on June 3-4 with the aim of disseminating and updating knowledge to help clinicians to diagnose, forecast, treat and follow patients in the most effective way as possible. Click here to read the report on the improvements made in the field of quality to reduce the incorrect interpretations of the clinical laboratory data.
EFLM bursaries programme - 14th EFLM Postgraduate Continuous Course in Dubrovnik - Deadline for applications: July 25, 2014
July 2, 2014 - This is to announce that EFLM is promoting a bursaries programme for young scientists attending the EFLM Course in Dubrovnik.
The bursaries will cover the cost of the travel and accommodation (max 3 nights in a 3* hotel or private accommodation) for a maximum of Eur 500. Kindly note that the registration fee is not refundable.
Eligible candidates must come from an EFLM Member Society and meet the following criteria:
- Young participants (≤40y at the date of the conference);
- Having a poster abstract accepted.
Applications must be accompanied with:
1) Short CV,
2) Copy of the ID or passport,
3) List of publications,
4) Document proving the membership to the National Society,
5) Notification of poster acceptance (notification of abstract acceptance/rejection will be sent by the congress organizers by July 15).
Preference shall be given to candidates with publications in Scientific Journals with high IF.
Please send your applications to email@example.com within September 4, 2014
Applicants will be notified of the bursaries acceptance by September 10, 2014.
EFLM presentations on Critical Results at the forthcoming AACC 2014 in Chicago
June 18, 2014 - We are pleased to announce that Eva Ajzner (Chair of the TFG-CR) and Rita Horvath (Consultant of the TFG-CR) will be delivering oral presentations on Critical Results at the forthcoming AACC 2014 Congress in Chicago in July.
The session will provide an overview of the current procedures in use in clinical laboratories for managing the communication of critical or significant risk results based on data from a recent survey organized by the TFG-CR and from a systematic review of published international surveys. The need for and a conceptual framework of establishing local policies and procedures in collaboration with clinical users will be emphasized. A hierarchical model for classifying sources of alert thresholds to assist laboratories in designing their alert result lists in a more evidence-based and transparent manner, and recent attempts to develop general guidelines in the field will also be addressed.
The EFLM-AACB TFG-CR´s session at the AACC meeting in Chicago is announced on the following webpage http://www.aacc.org/publications/cln/CLNStat/Lists/Posts/Post.aspx?ID=63
EFLM-BD Walter Guder Preanalytical Award 2014
June 1, 2014 - The Walter Guder Preanalytical Award 2014, presented by EFLM and sponsored by BD, has been granted to Dr. Johannes Zander for the article:
Effect of biobanking conditions on short-term stability of biomarkers in human serum and plasma
Johannes Zander, Mathias Bruegel, Alisa Kleinhempel, Susen Becker, Sirak Petros, Linda Kortz, Juliane Dorow, Jürgen Kratzsch, Ronny Baber, Uta Ceglarek, Joachim Thiery and Daniel Teupser
Inst. of Lab. Medicine, Clinical Chemistry and Molecular Diagnostics, University Leipzig, Leipzig, Germany
LIFE – Leipzig Research Center for Civilization Diseases, University Leipzig, Leipzig, Germany
Institute of Laboratory Medicine, Ludwig-Maximilians-University Munich, Munich, Germany
Medical ICU, University Leipzig, Leipzig, Germany
The Walter Guder Preanalytical Award is given to the best published paper, as judged by an independent panel of experts, which demonstrates a significant contribution to the improvement of the preanalytical phase. The award is intended to achieve wider recognition of the importance of high quality research in the field of the preanalytical phase among laboratory professionals in Europe. The Award will be presented to Dr. Zander, as the submitting author, during the EuroLabFocus Congress in Liverpool (7-10 October 2014). The award consists of certificate and a monetary award of EUR 5000, to be shared with co-authors, in addition to the cost of the participation to attend the Congress in Liverpool.
EFLM Speakers Bureau
EFLM has established a pool of EFLM speakers (from EFLM officers) to encourage NSs to engage EFLM speakers at their NSs meetings. These experienced speakers have been selected by the EFLM Committee on Education and Training according to their competence, accomplishments and their commitment to education.
Alphabet funding soup served on the 2014 Oxford Diagnostic Forum
On March 18-19 the 3rd Diagnostics Forum was held at the University of Oxford, UK, in the beautiful surroundings of Magdalen College. The meeting was sponsored by the UK Technology Strategy Board, the British In-Vitro Diagnostics Association, the UK National Institute for Health and Care Excellence, and the University of Oxford Nuffield Department of Primary Health Care’s Centre for Monitoring and Diagnosis.
These Diagnostics Fora form a special series of conferences, bringing together over 100 attendees, 2/5 of which from industry, 2/5 from academia and 1/5 from NICE, from the NHS, and other health care organizations. This mixed audience makes it a special and interesting event, and the format of the conference allows both communities to mix and mingle.
The focus of this year’s conference – for the first time in a two-day format – was on the generation of evidence to support the introduction of novel IVD, and on government support for the diagnostics industry in doing so. Overall, there were a few presentations and posters on the generation of evidence and the methods for doing so (from Jon Deeks and Elisabeth Adams, among others), but by and large the main focus of the meeting this year was on funding opportunities, in particular UK initiatives to stimulate innovation and collaboration in developing and evaluating diagnostics. Read more
BIAS and hypertriglyceridemia effect on risk score: an important study by the EAS-EFLM Cardiac Marker WG collaborative project group
A crucial study of the clinical impact of method bias in the cardiovascular risk classification based on HDL and LDL measurements in hypertriglyceridemia has been recently published in Atherosclerosis 2014;233:83-90. The study is part of the Collaborative Project Group between European Atherosclerosis Society (EAS) and EFLM, established by A Catapano (EAS President), J Chapman (EAS Past-president), and S Sandberg (previous EFLM Chair of Scientific Division, now EFLM President Elect) “…to produce laboratory testing recommendations and guidelines for management of dyslipidemia and prevention of cardiovascular disease”. Examining the results of a National External Quality Assessment, the group observed that direct HDL and LDL measurements are unreliable in hypertriglyceridemia and that these values should be used with caution in the SCORE risk classification and in related therapeutic approaches. The study deserves particular attention since it addresses the clinical outcomes of laboratory activities and emphasizes competencies in the interpretation of laboratory tests and in the invaluable role that Clinical Chemists may play in optimizing patient outcome.
Read the Abstract at http://www.atherosclerosis-journal.com/article/S0021-9150(13)00769-7/abstract
EU Directive 2005/36/EC: A new horizon to working across the European community
At a time when demand for highly qualified professionals across the EU is increasing and the labour force is declining, EFLM welcomes the passage in December 2013 of Directive 2005/36/EC (The recognition of professional qualifications) through the EU’s Parliament, Council and Commission. In supporting professional mobility across EU borders the Directive is a catalyst to ensuring a more equitable distribution of knowledge and skills across the community’s member states. EFLM’s Profession Committee will be at the forefront of shaping a common training framework for specialists in laboratory medicine and defining the equivalence of standards that ensures patients receive high quality, safe and equitable services wherever they are in the Community. The consolidated text for the Directive can be accessed at by clicking here.
For EFLM/EC4 national societies the passage of the Directive represents an opportunity for 9 EU member states to work with their governments to present the framework to the EU Commission. EU national societies are encouraged to liaise with their EC4 representatives for guidance on becoming a candidate state. In developing a common training framework EC4’s syllabus for education, training, knowledge and competency expectations represent the building blocks to which the input of all relevant stakeholders (firstname.lastname@example.org) will be also welcomed as we work to support the transposition of the Directive into national law.
EFLM Working Group on Cardiac Markers - Chair: Paivi Laitinen (FI)
The EFLM working group cardiac markers (EFLM-WG-CM) was originally constituted in 2010 with the brief to undertake an audit of current practice in cardiac biomarker testing in EFLM members via the national Clinical Chemistry/Biochemistry Societies. To date, we have undertaken three such surveys. On behalf on the WG-CM members we would like to extend our sincere thanks to all of those who have participated in the surveys. We all know that everyone is forever bombarded with surveys so we are very grateful to all who have participated. To those of you that have not, we would ask you to consider participating next time. We try and keep the surveys simple and they are web based. Read More - See also the slides posted by this WG
Report from the EFLM WG on Preanalytical Phase
The pre- and post-analytical phases of the laboratory testing process are now widely recognized as the major sources of laboratory errors. Preanalytical errors are the most common and account for up to 2/3 of the total number of errors. The risk of error in the laboratory testing process is underestimated in everyday clinical practice. The European Federation of Clinical Chemistry and Laboratory medicine (EFLM) working group on the preanalytical phase (WG-PRE) was established in 2010 to work on reducing the risk. Efficient indicators and educational tools are needed in order to implement the best preanalytical practices. Read More
Renewal of the agreement with CCLM
It is a pleasure to announce that the agreement on mutual cooperation between the European Federation of Laboratory Medicine (EFLM) and the Journal Clinical Chemistry and Laboratory Medicine (CCLM) has been renewed for the duration of another 5 years (2014-2018). CCLM is published on a monthly basis and is the most relevant Journal on Clinical Chemistry in Europe and is a valuable and updated source of knowledge for the scientific community and professionals in the field well recognized all over the world. The CCLM 2012 Impact factor is 3.009. Read more